Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
17.87
-0.53 (-2.88%)
At close: Dec 20, 2024, 4:00 PM
17.99
+0.12 (0.67%)
After-hours: Dec 20, 2024, 7:46 PM EST
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $13.18 billion as of December 20, 2024. Its market cap has increased by 746.98% in one year.
Market Cap
13.18B
Enterprise Value
12.72B
1-Year Change
746.98%
Ranking
Category
Stock Price
$17.87
Market Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $13.18B, an increase of 10,974.12%. That is a compound annual growth rate of 61.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 13.18B | 620.44% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avantor | 14.44B |
| Neurocrine Biosciences | 13.71B |
| Revvity | 13.70B |
| Fresenius Medical Care AG | 13.41B |
| Incyte | 13.26B |
| Dr. Reddy's Laboratories | 13.16B |
| Genmab | 12.97B |
| Insmed | 12.60B |